Kaempferol supplementation at 150 mg/kg improves reproductive performance of aged laying hens via modulation of the gut-liver-ovary axis Authors: Zhichao Xu, Yuanyuan Zhou, Shiyu Zheng, Yan Ren, Wenhai Qian, Sadequllah Ahmadi, Dikai Zhang, Rifu Xu, Ning Qin, Xue Sun Published: 2026 ABSTRACT The decline of egg production in aged laying hens is primarily due to age-related declines in hepatic and ovarian functions as well as changes in reproductive hormones and reduced antioxidant capacity. Kaempferol (KAE), a flavonoid compound with potent antioxidant activity also affects ovarian functions in mammals, but its role in chickens remains poorly understood. We aimed to investigate the potential of KAE to mitigate reproductive decline in aged laying hens through modulation of the gut-liver-ovary axis. A total of 400 Hy-Line Brown aged laying hens (420 days old) were randomly assigned to four groups consistent of five replicates with 20 hens per replicate and fed diets supplemented with either 0, 75, 150, or 300 mg/kg KAE. Dietary KAE significantly improved villus height and the villus height-to-crypt depth ratio in the duodenum, jejunum, and ileum.The mRNA expression of intestinal barrier–related genes (ZO-1, claudin-1, mucin, and occludin) were increased by dietary KAE, and partially enhanced intestinal absorption and barrier function. KAE also improved hepatic morphology, reduced hepatic triglyceride (TG) and total cholesterol (TC) levels, and significantly increased the expression of lipid synthesis and transport–related genes (FAS and MTTP). Moreover, the expression of yolk precursor synthesis–related genes including VTG-II, ApoVLDL-II, VLDLR, ER-α, ER-β, and PPAR-α were upregulated by KAE. Dietary KAE was effective in elevating the level of estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and progesterone (P4), and upregulating the mRNA transcripts of ER-α, ER-β, FSHR, and LHR in ovary. Additionally, KAE was effective in enhancing the ovarian antioxidant capacity, while reducing reactive oxygen species (ROS) accumulation, and inhibiting apoptosis in prehierarchical follicles. In conclusion, 150 mg/kg KAE is the optimum dose improving intestinal integrity and hepatic metabolism, promoting follicular development and steroid hormone secretion, and ultimately enhancing egg production performance by modulating the gut-liver-ovary axis in aged laying hens. Introduction The aging of laying hens is characterized by a progressive decline in hepatic and ovarian functions, accompanied by reduced antioxidant capacity, altered secretion of reproductive hormones, decreased transport and accumulation of yolk precursors in oocytes, and depletion of follicle reserves, ultimately leading to decreased egg production (Hao et al., 2021;Bao et al., 2022;He et al., 2023). Among these factors, oxidative stress is a key factor driving the decline in the productive performance of aged laying hens. The oxidation-antioxidant system in aged hens is severely imbalanced, and excessive reactive oxygen species (ROS) cause oxidative damage to oocytes and granulosa cells in their follicles. This leads to altered ovarian function, characterized by reduced steroid hormone levels and increased follicular atresia, resulting in decreased egg production and caused significant economic losses to the poultry industry (Lim et al., 2015; Colella et al., 2021; Wu et al., 2023). Therefore, improving the functions of the intestine, liver, and ovary is crucial for mitigating the decline in egg production and maintaining egg quality. The gut-liver-ovary signaling axis involves complex bidirectional interplay, mediated by nutrients, hormonal signals, and immune factors (Nicholson et al., 2012; Cryan et al., 2020; Dai et al., 2022). The intestine, as a vital site for the digestion and absorption of nutrients from feed, directly transports these absorbed nutrients to the liver via the portal vein. The liver is a key target organ of the gut-liver axis and is directly influenced by the intestinal microbiota. Naturally, these processes are primarily regulated by reproductive hormones (including estrogen). In laying hens during their peak laying period, estrogen upregulates the transcription of vitellogenin II (VTG-II) and apolipoprotein Very-Low-Density Lipoprotein II (ApoVLDL-II) by binding to estrogen receptor (ER)-α and ER-β in the liver. Meanwhile, Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) coordinates lipid metabolism, providing triglyceride substrates for the assembly of yolk-targeted Very Low-Density Lipoprotein (VLDLy). After synthesis, the yolk precursors (VTG-II and VLDLy) are secreted into the bloodstream and subsequently internalized via receptor-mediated endocytosis through the very low-density lipoprotein receptor (VLDLR) on the oocyte membrane, forming yolk granules that supply essential nutrients for oocyte development (Cui et al., 2020; Alvarenga et al., 2011; Amevor et al., 2021), thereby ensuring successful egg production. However, after the peak laying period, the physiological state of hens undergoes a series of degenerative changes. Oxidative stress attacks all cells in the body, with the most severe damage occurring in the gut-liver-ovary axis. This leads to impaired intestinal barrier function, reduced hepatic lipid metabolism, disrupted reproductive hormone secretion, and increased ovarian oxidative stress, all of which significantly affect follicular development and laying performance (Liu et al., 2026; Zhang et al., 2025; Li et al., 2024; Hu et al., 2025). Therefore, enhancing the antioxidant defense capacity of these organs to promote endocrine function in aged laying hens is of critical importance. Kaempferol (KAE) is a flavonoid compound belonging to the flavonol subclass and is structurally similar to quercetin. KAE is widely found in berries, leafy green vegetables, and tea, and possesses high antioxidant activity as well as anti-inflammatory and anti-cancer effects (Periferakis et al., 2022). Recent studies have shown that KAE can enhance the expression and activity of antioxidant enzymes such as catalase and glutathione peroxidase under oxidative stress conditions, thereby alleviating oxidative damage in mouse liver tissue (Shakya et al., 2013). KAE can also promote the activation of primordial follicles and cell proliferation in sheep ovaries via the PI3K/protein kinase B (AKT) pathway, and promote the development of secondary follicles through the phosphatidylinositol 3-kinase signaling pathway (Santos et al., 2019). Furthermore, recent studies in poultry have demonstrated that dietary KAE supplementation can improve ovarian function and promote follicular development in aged hens, although the underlying molecular mechanisms remain largely unexplored (Zhang et al., 2025). Thus, it is evident that KAE exhibits excellent antioxidant effects. Despite these promising findings in mammals and cell models, the application of KAE in poultry production, particularly in aged laying hens, remains largely unexplored. Current evidence on flavonoids in hens has primarily focused on quercetin, daidzein, and rutin, with limited data on KAE's specific effects on the gut-liver-ovary axis. Moreover, existing studies have not systematically evaluated the dose-dependent effects of KAE on the integrative physiological network connecting intestinal barrier function, hepatic yolk precursor synthesis, and ovarian steroidogenesis in aged hens. Therefore, the optimal dosage and the underlying mechanisms by which KAE ameliorates reproductive decline in aged laying hens require elucidation. Numerous studies have demonstrated that natural flavonoids (e.g., quercetin, daidzein) alleviate ovarian oxidative stress and improve late-period laying performance in hens (Shi et al., 2013; Shen et al., 2016; Wei et al., 2024). However, research on KAE in poultry, particularly in aged laying hens, remains limited. Four critical gaps persist: (1) most KAE data derive from mammalian/cell models, not poultry; (2) no dose-response study has established the optimal dosage for aged hens; (3) KAE's effects on the gut-liver-ovary axis have not been evaluated; and (4) its molecular mechanisms in poultry are unclear. To address these gaps, this study was designed to: (1) determine the optimal KAE dosage via a dose-response trial (0, 75, 150, and 300 mg/kg); (2) evaluate intestinal morphology and barrier function; (3) assess hepatic lipid metabolism and yolk precursor synthesis; (4) investigate ovarian antioxidant capacity, follicular development, and hormone secretion, all within the gut-liver-ovary axis framework. Materials and methods Animals and experimental design A total of 400 Hy-Line Brown aged laying hens (420 days old) were purchased from the Blue Valley Cooperative (Gongzhuling, Jilin Province, China) and housed at the Gongzhuling Rice–Fish Science and Technology Demonstration Base for the feeding trial. The experiment included a 1-week adaptation period followed by a 10-weeks formal trial. A single-factor experimental design was adopted, and the birds were randomly assigned to four treatment groups with five replicates per group and 20 hens per replicate as follows: Control group (CON): basal diet; KAE1: basal diet + 75 mg/kg KAE; KAE2: basal diet + 150 mg/kg KAE; KAE3: basal diet + 300 mg/kg KAE. Table 1 shows the composition and nutrient levels of the basal diet. The supplementation levels of KAE (0, 75, 150, and 300 mg/kg) were determined based on preliminary trials conducted by our research group (Supplementary Table S1). KAE (purity ≥ 98%, extracted from Sophora japonica) was supplied by Shaanxi Botao Biotechnology Co., Ltd. (Shan’xi, China). The hens were kept in single cages with free access to feed and water. The ambient temperature was maintained between 19°C and 24°C under 16-h light and 8-h dark lighting regimen. Additionally, all experimental procedures were approved by the Animal Protection and Utilization Committee of Jilin Agricultural University (Changchun, China; Permission No. GR (J) 240520006, approved on May 20, 2024).Table 1Diet composition and nutrient levels (dry matter basis). The nutrition level refers to the Chicken Feeding Standard (NY/T 33-2004).Ingredients (%)ContentCorn61.92Soybean Meal18.00Fish Meal1.00DDGS8.00CaHPO42.00Limestone8.50Salt0.35Lysine0.10Methionine0.050.03% Poultry Vitamin Premix10.030.20% Trace Mineral Premix20.20Betaine Hydrochloride0.20Total100.00Nutrient compositionMetabolisable Energy (MJ/kg)11.05Crude protein (%)15.39Calcium (%)3.53Total Phosphorus (%)0.61Lysine (%)0.86Threonine (%)0.66Methionine + Cysteine (%)0.64Note:.1: Trace mineral premix provided per kg of diet: Cu 15 mg, Zn 60 mg, Fe 96 mg, Mn 66 mg, K 0.5 mg, Na 0.2 mg.2: Vitamin premix provided per kg of diet: VA 4,000,000 IU, VD 1,250,000 IU, VE 10,000 IU, VK 1,000 mg, VB1 8,000 mg, VB2 25,000 mg, VB6 15,000 mg, VB12 10,000 mg. Table 1Diet composition and nutrient levels (dry matter basis). The nutrition level refers to the Chicken Feeding Standard (NY/T 33-2004).Ingredients (%)ContentCorn61.92Soybean Meal18.00Fish Meal1.00DDGS8.00CaHPO42.00Limestone8.50Salt0.35Lysine0.10Methionine0.050.03% Poultry Vitamin Premix10.030.20% Trace Mineral Premix20.20Betaine Hydrochloride0.20Total100.00Nutrient compositionMetabolisable Energy (MJ/kg)11.05Crude protein (%)15.39Calcium (%)3.53Total Phosphorus (%)0.61Lysine (%)0.86Threonine (%)0.66Methionine + Cysteine (%)0.64Note:.1: Trace mineral premix provided per kg of diet: Cu 15 mg, Zn 60 mg, Fe 96 mg, Mn 66 mg, K 0.5 mg, Na 0.2 mg.2: Vitamin premix provided per kg of diet: VA 4,000,000 IU, VD 1,250,000 IU, VE 10,000 IU, VK 1,000 mg, VB1 8,000 mg, VB2 25,000 mg, VB6 15,000 mg, VB12 10,000 mg. Diet composition and nutrient levels (dry matter basis). The nutrition level refers to the Chicken Feeding Standard (NY/T 33-2004). Note:. 1: Trace mineral premix provided per kg of diet: Cu 15 mg, Zn 60 mg, Fe 96 mg, Mn 66 mg, K 0.5 mg, Na 0.2 mg. 2: Vitamin premix provided per kg of diet: VA 4,000,000 IU, VD 1,250,000 IU, VE 10,000 IU, VK 1,000 mg, VB1 8,000 mg, VB2 25,000 mg, VB6 15,000 mg, VB12 10,000 mg. Laying performance and sample collection Laying performance was recorded daily according to the Poultry Production Performance Measurement and Statistical Method (NY/T823-2004). Egg number and egg weight were recorded daily for each replicate. To calculate the egg-laying rate, average daily feed intake, average egg weight, and feed-to-egg ratio, feed consumption was documented weekly. At 60 weeks of age (end of the feeding trial), six hens were randomly selected from each group for sampling. All samples were collected between 8:00 and 10:00 AM, approximately 2–4 h after oviposition, to minimize variation associated with the ovulatory cycle. After weighing, blood was collected from the wing vein and centrifuged at 3,000 rpm for 10 min at 4°C to obtain serum, and stored at −20°C until analysis. Subsequently, the hens were euthanized by ether anesthesia, followed by immediate collection of liver, gut, ovary, and prehierarchical follicles (1–8 mm in diameter). Liver and ovarian tissues (0.5 × 0.5 × 0.5 cm blocks collected from the central region of the ovary, containing representative follicular populations of primordial, primary, secondary, and prehierarchical follicles) and intestinal segments (duodenum, jejunum, and ileum; 1 cm from the middle section) were fixed in 4% paraformaldehyde for histological analysis. The remaining samples were snap-frozen in liquid nitrogen and stored at −80°C until further use. Histological staining After 24 h of paraformaldehyde fixation, liver samples were cryoembedded and sectioned by Leica CM1950 cryostat (Leica Biosystems, Germany). The frozen liver sections were then subjected to Oil Red O staining for lipid deposition analysis. Ovarian and intestinal tissues were dehydrated with graded ethanol washed with xylene, and embedded in paraffin. The tissues were then sectioned using a Leica RM2235 microtome followed by hematoxylin and eosin staining (HE). Histological morphology was observed under a Leica DM4B light microscope (Leica Biosystems, Germany). For follicle counting, at least 5 non-overlapping fields per section at 400 × magnification were examined. Follicles were classified as: primordial follicles (oocyte surrounded by a single layer of flattened granulosa cells), primary follicles (oocyte surrounded by a single layer of cuboidal granulosa cells), secondary follicles (oocyte surrounded by multiple layers of granulosa cells), and atretic follicles (follicles with apoptotic granulosa cells, pyknotic nuclei, or irregular oocyte shape). Only follicles containing a clearly visible oocyte nucleus were counted. RNA isolation and quantitative real-time PCR Frozen tissues were ground into fine powder in liquid nitrogen. For ovarian gene expression analysis, whole prehierarchical follicles (1–8 mm in diameter) were used. These follicles were carefully dissected from the ovary, immediately snap-frozen in liquid nitrogen, and stored at −80°C until RNA extraction. Frozen tissues were then ground into fine powder in liquid nitrogen. Total RNA was extracted using TRIzol reagent in accordance with the manufacturer's protocol (Thermo Fisher Scientific, Waltham, MA, USA). After lysis for 10 min, 300 μL chloroform (Nanjing Reagent, Nanjing, China) was added, and samples were vigorously mixed, incubated for 10 min, centrifuged at 12,000 rpm for 5 min at 4°C, and the supernatant was collected. RNA was precipitated with an equal volume of isopropanol and washed with 75% ethanol. The RNA pellet was dissolved in DEPC water (Biosharp, Shanghai, China). RNA purity and concentration were assessed using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), all samples exhibited A260/A280 ratios between 1.8 and 2.0 and A260/A230 ratios above 2.0, indicating high RNA purity. RNA integrity was further verified by electrophoresis on a 1.2% agarose gel, showing clear 28S and 18S RNA bands. Complementary DNA (cDNA) was synthesized from 1 µg of total RNA using a PrimeScript RT reagent kit (Takara Bio, Beijing, China) with random hexamer primers. The reaction was performed in a 20 µL volume at 37°C for 15 min, followed by 85°C for 5 sec to inactivate the reverse transcriptase. β-actin was used as the reference gene and its stability was validated across all treatment groups, with Ct values ranging from 18 to 22 and showing no significant differences among groups. All qRT-PCR primers were designed using Primer Premier 5.0 software (Premier Biosoft, CA, USA) and synthesized by Sangon Biotech (Shanghai, China). Primer sequences are listed in Table 2. Quantitative real-time PCR was performed using TB Green Premix Ex Taq II (Takara Bio, Beijing, China) on a LightCycler 96 System (Roche, Basel, Switzerland). Each 10 µL reaction contained 5 µL of TB Green Premix Ex Taq II (2 ×), 0.4 µL each of forward and reverse primers (10 µM), 1 µL of cDNA template (diluted 1:5), and 3.2 µL of RNase-free water. The thermal cycling protocol was: initial denaturation at 95°C for 30 sec; 40 cycles of 95°C for 5 sec and 60°C for 30 sec. Melt curve analysis was performed from 65°C to 95°C with 0.5°C increments to verify amplification specificity. No-template controls (NTCs) were included in each run and were all negative. Relative gene expression was calculated using the 2⁻ΔΔCt method. All reactions were performed in triplicate for both biological (n = 6 per group) and technical replicates. All qRT-PCR experiments were performed and reported in accordance with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) 2.0 guidelines. A completed MIQE checklist is provided as Supplementary Table S2. To determine the amplification efficiency of each primer pair, standard curves were generated using 5-point 10-fold serial dilutions of pooled cDNA (ranging from 100 ng to 0.01 ng). Each dilution was run in triplicate. The PCR efficiency (E) was calculated from the slope of the standard curve according to the formula: E = 10^(−1/slope)−1. All primer pairs exhibited amplification efficiencies between 90% and 110% (R² > 0.99). The efficiency values for all targets are provided in Supplementary Table S3.Table 2Primer pairs designed for the quantitative real-time PCR analysis.GenesPrimer sequences(5′- 3′)length(bp)ZO-1F:AGACCATTCCAGACATTCTCCACAGR:TGTAGAGATGGCTCCTGGTTTAGTTAC92Claudin-1F:GGGTCTGGTTGGTGTGTTTGTTGR:AGACAGCCATCCGCATCTTCTTC92mucin-2F:ACCATAGTTACCACAAGTCGTCCAGR:TCATAGTCACCACCATCTTCTTCAGG113occludinF: CTACGGCAGCACCTACCTCAACR:CCCACAGACAGCCACAG82ER-αF:GTTCCGCTCTACGACCTCTTACTGR:AGYYGGYYYCGGTTCTCCTCTTCC104ER-βF: GTATGACTTGCTGGAGATGTTGR: TCAGACCTGGAAATGTGAAACTTGTTC106ApoVLDL-ⅡF:ACGAAGCTGTGAACAAGGTGTCCR:TCCGCCAGTTTAGTGAGTCTAGCC127FASF:ACATGGAATGGGAGGAGCCTACGR:TCCTTTCCTGGTGGCTGCAAAC109MTTPF:AGTTGGCTCTCCTTTCAGGCATTCR:TTTCCCTCTCCTCGCAGTGTACC82PPAR-αF:CATGGCAGAGAAGACGCTGGTGR:TCTACAGAGGTACACTGGCAGCAG102VTG-ⅡF:TGCCTCCTCAACTGCCACCTCR:CTGTTACTGCTCTTGCTGCTCCTG150VLDLRF:AACGAGGCAGTCTATGGTGCR:TGTTGAATCCTCCACATCTCAG271FSHRF:TTCCTGTGCTAACCCTTTCCTCTATGR:CTCTGTTCTGTAAATCTGGGCTTGC118LHRF:CGGATACGCAACGATGCCCTGAGR:ACATTGCATTGAGGACCTGGATGG121ATP6F:CAGCCAAGACTACCATGAACAAAGCR:CAGCCACCACTAGCGAGACAC106COX-1F:CATGGTTGTGATGATGGTGCTTCCR:ACTGCTCCATTTCCCGTCTCATATC98ND1F:GCGAGACTCTGATAGCATTTTAGAAGCR:CACAAGCACCCAAGCATTCCAC116BaxF:GATGACTTCAACTACGGCAGCAACR:GTCAAGAGAACCTGAATGGACAGGAATG104Bcl-2F:TTGTGGAATTGTACGGCAACAGTATGR:CACCAGAACCAGGCTCAGGATG86Caspase9F:AACGCTTCTCCATCGCAGTCCR:GTCTGTGGTCACCCCTGTCAAC96β-actinF:GCCAACAGAGAGAAGATGACACAGR:CATCACCAGAGTCCATCACAATACC133 Table 2Primer pairs designed for the quantitative real-time PCR analysis.GenesPrimer sequences(5′- 3′)length(bp)ZO-1F:AGACCATTCCAGACATTCTCCACAGR:TGTAGAGATGGCTCCTGGTTTAGTTAC92Claudin-1F:GGGTCTGGTTGGTGTGTTTGTTGR:AGACAGCCATCCGCATCTTCTTC92mucin-2F:ACCATAGTTACCACAAGTCGTCCAGR:TCATAGTCACCACCATCTTCTTCAGG113occludinF: CTACGGCAGCACCTACCTCAACR:CCCACAGACAGCCACAG82ER-αF:GTTCCGCTCTACGACCTCTTACTGR:AGYYGGYYYCGGTTCTCCTCTTCC104ER-βF: GTATGACTTGCTGGAGATGTTGR: TCAGACCTGGAAATGTGAAACTTGTTC106ApoVLDL-ⅡF:ACGAAGCTGTGAACAAGGTGTCCR:TCCGCCAGTTTAGTGAGTCTAGCC127FASF:ACATGGAATGGGAGGAGCCTACGR:TCCTTTCCTGGTGGCTGCAAAC109MTTPF:AGTTGGCTCTCCTTTCAGGCATTCR:TTTCCCTCTCCTCGCAGTGTACC82PPAR-αF:CATGGCAGAGAAGACGCTGGTGR:TCTACAGAGGTACACTGGCAGCAG102VTG-ⅡF:TGCCTCCTCAACTGCCACCTCR:CTGTTACTGCTCTTGCTGCTCCTG150VLDLRF:AACGAGGCAGTCTATGGTGCR:TGTTGAATCCTCCACATCTCAG271FSHRF:TTCCTGTGCTAACCCTTTCCTCTATGR:CTCTGTTCTGTAAATCTGGGCTTGC118LHRF:CGGATACGCAACGATGCCCTGAGR:ACATTGCATTGAGGACCTGGATGG121ATP6F:CAGCCAAGACTACCATGAACAAAGCR:CAGCCACCACTAGCGAGACAC106COX-1F:CATGGTTGTGATGATGGTGCTTCCR:ACTGCTCCATTTCCCGTCTCATATC98ND1F:GCGAGACTCTGATAGCATTTTAGAAGCR:CACAAGCACCCAAGCATTCCAC116BaxF:GATGACTTCAACTACGGCAGCAACR:GTCAAGAGAACCTGAATGGACAGGAATG104Bcl-2F:TTGTGGAATTGTACGGCAACAGTATGR:CACCAGAACCAGGCTCAGGATG86Caspase9F:AACGCTTCTCCATCGCAGTCCR:GTCTGTGGTCACCCCTGTCAAC96β-actinF:GCCAACAGAGAGAAGATGACACAGR:CATCACCAGAGTCCATCACAATACC133 Primer pairs designed for the quantitative real-time PCR analysis. Determination of hepatic lipid content and ovarian oxidative stress Approximately 0.1 g of liver tissue was homogenized on ice in 1 mL of extraction buffer or ethanol, centrifuged at 12,000 rpm for 10 min at 4°C, followed by supernatant collection. The supernatant was used to determine TG and TC using commercial assay kits (Jiangsu Addison Biological Technology Co., Ltd., China) according to the manufacturer’s instructions. In addition, the absorbance was measured at 510 nm using a spectrophotometer. For ovarian oxidative stress analysis, ovaries were dissected within 3-5 min post-euthanasia, trimmed of peripheral fat, oviduct, and mesovarium, and rinsed with pre-chilled sterile PBS to remove residual blood. Only the ovarian cortical region (containing follicles at various developmental stages and granulosa-theca cells) was collected as the sample, while the medullary region was discarded, 0.1 g of ovarian tissue was homogenized in 1 mL PBS and centrifuged at 12,000 rpm for 10 min at 4°C. The supernatant was collected to determine oxidative stress indicators using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Total superoxide dismutase (T-SOD) and MDA levels were measured at 550 nm and 532 nm, respectively. Catalase (CAT) activity was determined at 240 nm, and glutathione peroxidase (GSH-Px) activity was determined at 412 nm. ROS levels were quantified using an ELISA kit with absorbance measured at 450 nm. Hormone determination Serum concentrations of estradiol (E2), progesterone (P4), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were determined using chicken-specific enzyme-linked immunosorbent assay (ELISA) kits (Meibiao Biological Technology Co., Ltd., Jiangsu, China) according to the manufacturers' instructions. The kit catalog numbers were as follows: E2 (Cat. No. MB-4608B), FSH (Cat. No. MB-2658B), LH (Cat. No. MB-2659B), and P4 (Cat. No. MB-4609B). All kits were validated for chicken serum samples. The intra- and inter-assay coefficients of variation (CV) were < 10% and < 12%, respectively, as reported by the manufacturers. Absorbance was read at 450 nm using a spectrophotometer (Thermo Fisher Scientific, Shanghai, China). Briefly, 50 μL of diluted standards or serum samples and 50 μL of biotin-labeled antibody were added to the wells, incubated at 37°C for 1 h, washed three times, and incubated with enzyme conjugate for 15 min. After color development and reaction termination, absorbance was read at 450 nm using a spectrophotometer (Thermo Fisher Scientific, Shanghai, China). Statistical analysis All data were first tested for normality using the Shapiro-Wilk test and for homogeneity of variance using Levene's test. When both assumptions were met, data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey's honest significant difference (HSD) post-hoc test for multiple comparisons. When data did not meet these assumptions, the Kruskal-Wallis non-parametric test was applied, followed by Dunn's post-hoc test with Bonferroni correction. Results are presented as mean ± standard error (SE). Different superscript letters indicate significant differences (p < 0.05). All statistical analyses were performed using SPSS software (version 23.0; SPSS Inc., Chicago, IL, USA). All qRT-PCR reactions were performed in triplicate for each sample. Results KAE improves productive performance in aged laying hens We first evaluated the effects of dietary supplementation with different levels of KAE on the productive performance of aged laying hens. As shown in Table 3, KAE supplementation increased the laying rate in all groups compared with the CON; the KAE2 (150 mg/kg KAE) exhibited a significantly higher laying rate than the CON, KAE1, and KAE3 groups (p < 0.05). The average daily feed intake in the KAE2 group showed no significant difference compared with the CON, KAE1, and KAE3 groups (p > 0.05). Additionally, compared to CON, the average egg weight was significantly higher in the KAE1, KAE2, and KAE3 groups (p < 0.05). The KAE2 group had a significantly lower FCR (feed/egg ratio) than the CON and KAE1 groups (p < 0.05), with no significant difference compared with the KAE3 group (p > 0.05).Table 3Effects off dietary KAE supplementation on production performance of aged laying hens.ItemsGroupsCONKAE1KAE2KAE3Egg laying rate (%)82.20 ± 1.18b82.90 ± 1.58b86.20 ± 2.28a83.10 ± 1.58bAverage daily feed intake(g)123.03 ± 1.87123.71 ± 5.99119.19 ± 3.81122.28 ± 2.98Average egg weight (g)61.31 ± 0.810a62.03 ± 1.34ab63.49 ± 1.78b63.28 ± 1.82bFeed/egg ratioa2.12 ± 0.04b2.11 ± 0.53b2.04 ± 0.06a2.09 ± 0.21abNote:Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05).aFeed/egg ratio = daily feed consumption/average egg weight. Data are presented as the mean ± SE. Table 3Effects off dietary KAE supplementation on production performance of aged laying hens.ItemsGroupsCONKAE1KAE2KAE3Egg laying rate (%)82.20 ± 1.18b82.90 ± 1.58b86.20 ± 2.28a83.10 ± 1.58bAverage daily feed intake(g)123.03 ± 1.87123.71 ± 5.99119.19 ± 3.81122.28 ± 2.98Average egg weight (g)61.31 ± 0.810a62.03 ± 1.34ab63.49 ± 1.78b63.28 ± 1.82bFeed/egg ratioa2.12 ± 0.04b2.11 ± 0.53b2.04 ± 0.06a2.09 ± 0.21abNote:Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05).aFeed/egg ratio = daily feed consumption/average egg weight. Data are presented as the mean ± SE. Effects off dietary KAE supplementation on production performance of aged laying hens. Note:Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05). Feed/egg ratio = daily feed consumption/average egg weight. Data are presented as the mean ± SE. KAE enhances intestinal morphology and barrier integrity Histological changes in the duodenum, jejunum, and ileum were evaluated by HE staining (Fig. 1A), and villus height (VH), crypt depth (CD), and villus height-to-crypt depth (V/C) ratio were quantified (Table 4). Compared with the CON group, dietary KAE supplementation significantly increased VH in all three intestinal segments (p < 0.05); particularly the KAE2 group exhibited the greatest increase in VH across the duodenum, jejunum, and ileum when compared with the KAE1 and KAE3 groups (p < 0.05). In contrast to the CON group, CD was significantly lower in the jejunum and ileum of the KAE2 group (p < 0.05), while no significant differences were observed in duodenal CD between KAE1 and KAE2 (p > 0.05). However, CD in KAE2 was significantly lower than that in KAE3 (p < 0.05). Consequently, the V/C ratios were markedly higher in all KAE groups than in the control, with the KAE2 group showing the highest values among all treatments (p < 0.05).Fig. 1Effect of dietary KAE supplementation on intestinal morphology in duodenum, jejunum and ileum and mRNA expression of gut barrier related genes of aged laying hens. (A) Hematoxylin and eosin (HE) staining images of duodenum, jejunum and ileum (400x), (B-E) The mRNA expression of gut barrier related genes ZO-1, claudin-1, mucin and occludin. Data are presented as the mean ± SE. Different letters mean significant differences (p < 0.05).Table 4Determination results of Intestinal morphology indexes of aged laying hens.Intestinal morphology indexesCONKAE1KAE2KAE3DuodenumVH1097.737 ± 21.041c1451.467 ± 26.293b1541.670 ± 32.657a1467.424 ± 29.463bCD185.480 ± 4.000a160.265 ± 3.120bc155.406 ± 3.29c165.777 ± 3.028bVCR5.935 ± 0.255c9.068 ± 0.067b9.948 ± 0.077a8.837 ± 0.0677bJejunumVH849.188 ± 23.643d966.657 ± 19.293c1442.877 ± 43.657a1200.775 ± 34.463bCD223.326 ± 3.0004a190.461 ± 2.046c182.213 ± 3.097d209.572 ± 3.092bVCR3.807 ± 0.057d5.084 ± 0.054c7.929 ± 0.109a5.719 ± 0.102bIleumVH716.597 ± 16.642c792.345 ± 17.293b945.596 ± 22.657a918.785 ± 24.463aCD195.965 ± 3.003a166.239 ± 2.015b152.086 ± 3.030c163.37 ± 2.946bVCR3.215 ± 0.024d4.168 ± 0.328c6.272 ± 0.513a5.632 ± 0.077bNote:VH(μm): Villi height, CD(μm): crypt depth and VCR: villus/crypt ratio. Data are presented as the mean ± SE. Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05).algr. Effect of dietary KAE supplementation on intestinal morphology in duodenum, jejunum and ileum and mRNA expression of gut barrier related genes of aged laying hens. (A) Hematoxylin and eosin (HE) staining images of duodenum, jejunum and ileum (400x), (B-E) The mRNA expression of gut barrier related genes ZO-1, claudin-1, mucin and occludin. Data are presented as the mean ± SE. Different letters mean significant differences (p < 0.05). Table 4Determination results of Intestinal morphology indexes of aged laying hens.Intestinal morphology indexesCONKAE1KAE2KAE3DuodenumVH1097.737 ± 21.041c1451.467 ± 26.293b1541.670 ± 32.657a1467.424 ± 29.463bCD185.480 ± 4.000a160.265 ± 3.120bc155.406 ± 3.29c165.777 ± 3.028bVCR5.935 ± 0.255c9.068 ± 0.067b9.948 ± 0.077a8.837 ± 0.0677bJejunumVH849.188 ± 23.643d966.657 ± 19.293c1442.877 ± 43.657a1200.775 ± 34.463bCD223.326 ± 3.0004a190.461 ± 2.046c182.213 ± 3.097d209.572 ± 3.092bVCR3.807 ± 0.057d5.084 ± 0.054c7.929 ± 0.109a5.719 ± 0.102bIleumVH716.597 ± 16.642c792.345 ± 17.293b945.596 ± 22.657a918.785 ± 24.463aCD195.965 ± 3.003a166.239 ± 2.015b152.086 ± 3.030c163.37 ± 2.946bVCR3.215 ± 0.024d4.168 ± 0.328c6.272 ± 0.513a5.632 ± 0.077bNote:VH(μm): Villi height, CD(μm): crypt depth and VCR: villus/crypt ratio. Data are presented as the mean ± SE. Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05).algr. Determination results of Intestinal morphology indexes of aged laying hens. Note:VH(μm): Villi height, CD(μm): crypt depth and VCR: villus/crypt ratio. Data are presented as the mean ± SE. Different lowercase letter superscripts mean notable differences (p < 0.05). Values with the same or no letters mean no significant difference (p > 0.05).algr. The mRNA expression levels of intestinal barrier-related genes were also altered by dietary KAE supplementation which may have resulted in improved intestinal barrier integrity (Fig. 1B-E). The mRNA expression levels of tight junction-related genes, including ZO-1, claudin-1 were significantly enhanced in the KAE2 and KAE3 compared with the CON and KAE1 groups (p < 0.05). However, no dietary KAE supplementation significantly altered the Mucin-2 and Occludin-1 transcripts. KAE improves hepatic lipid metabolism and yolk precursor synthesis Next, we analyzed the effects of dietary KAE on hepatic lipid metabolism and yolk precursor synthesis in aged laying hens. As shown in Fig. 2A-D, KAE supplementation markedly reduced (p < 0.05) hepatic lipid droplet density and the concentrations of TC and TG compared with the CON. The KAE2-supplemented birds displayed a notably lower lipid droplet density and TG content compared with the KAE1- and KAE3-supplemented birds (p < 0.05).Fig. 2Effects of dietary KAE supplementation on liver lipid metabolism of aged laying hens (A) Oil Red O staining of liver tissue (400x), (B) lipid droplet content, (C) total cholesterol level, (D) triglyceride level. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). Effects of dietary KAE supplementation on liver lipid metabolism of aged laying hens (A) Oil Red O staining of liver tissue (400x), (B) lipid droplet content, (C) total cholesterol level, (D) triglyceride level. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). In comparison to CON, the gene expression level of FAS was enhanced in all KAE supplemented birds (p < 0.05) but markedly higher in the KAE2 group (Fig. 3A and B). The MTTP transcript showed a similar trend to FAS, with significantly higher expression in all KAE supplemented groups compared with the CON group (p < 0.05). Furthermore, the yolk precursor synthesis-related genes, ER-α and ER-β, and the yolk precursor synthesis genes, ApoVLDL-II, VTG-II, and VLDLR, were significantly upregulated (p < 0.05) in all KAE groups compared to CON, with the highest expression observed in KAE2 (Fig. 3C—H). The mRNA level of PPARα was also significantly higher in KAE2 and KAE3 compared with the CON and KAE1 groups (p < 0.05).Fig. 3Effects off dietary KAE supplementation on expression of genes related to yolk precursor formation in the liver of aged laying hens. (A-H) The expression level of ER-α, ER-β, ApoVLDL-II, VTG-II, VLDLR, PPAR-a, FAS, MTTP in the liver. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). Effects off dietary KAE supplementation on expression of genes related to yolk precursor formation in the liver of aged laying hens. (A-H) The expression level of ER-α, ER-β, ApoVLDL-II, VTG-II, VLDLR, PPAR-a, FAS, MTTP in the liver. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). KAE regulates reproductive hormone secretion and receptor expression As shown in Fig. 4A-C, serum concentrations of E2, P4, and LH were significantly elevated in all KAE-supplemented groups compared with the CON (p < 0.05). The serum concentrations of FSH in KAE2 and KAE3 were significantly higher (p < 0.05) in KAE2 compared with the CON and KAE1 groups (Fig. 4D). Compared to other groups, all KAE2-supplemented groups showed significantly higher serum concentrations of E2, P4, LH, and FSH. The surge of these hormones was particularly much higher in KAE2 group. Following this, we analyzed the mRNA expression levels of the corresponding hormone receptor genes (ER-α, ER-β, FSHR, and LHR) in the same whole prehierarchical follicles (Fig. 4E-H). The mRNA expression levels of ER-α and ER-β, FSHR, and LHR were significantly enhanced in the KAE2 group (p < 0.05), whereas no significant differences were found among the other groups (p > 0.05). The expression of FSHR was upregulated in all KAE groups (p < 0.05), with the highest expression in KAE2. Similarly, LHR mRNA levels were highest in KAE2 (p < 0.05).Fig. 4Effect of dietary KAE supplementation on the levels of serum reproductive hormone and their receptors of aged laying hens. (A-D) The levels of serum E2, P4, LH,and FSH (E-H) The mRNA expression of hormone receptors in the ovary of late-laying hens. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). Effect of dietary KAE supplementation on the levels of serum reproductive hormone and their receptors of aged laying hens. (A-D) The levels of serum E2, P4, LH,and FSH (E-H) The mRNA expression of hormone receptors in the ovary of late-laying hens. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). KAE attenuates ovarian oxidative stress As shown in Fig. 5A, HE revealed a significant decrease in the populations of primordial follicles (PrFs), primary follicles (PFs), and secondary follicles (SFs), whereas the number of atretic follicles (AtFs) were significantly increased. And normal ovarian morphology was observed across all groups. HE staining revealed that KAE-supplemented hens exhibited significantly increased populations of growing follicles and primary follicles (PFs), significantly decreased numbers of atretic follicles (AFs), and a denser medullary structure (M) compared with the CON group, suggesting that KAE may promote granulosa cells development.Fig. 5Effect of dietary KAE supplementation on the histology and antioxidant capacity of the aged laying hens ovary. (A) HE staining of the ovary tissue of late-laying hens (40x and 100x). Abbreviations: AF, atretic follicles; PF, primary follicles; M, medulla, (B-F) The antioxidant capacity and MDA levels of the ovary. Abbreviations: ROS, reactive oxygen species; GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; MDA, malondialdehyde. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). Effect of dietary KAE supplementation on the histology and antioxidant capacity of the aged laying hens ovary. (A) HE staining of the ovary tissue of late-laying hens (40x and 100x). Abbreviations: AF, atretic follicles; PF, primary follicles; M, medulla, (B-F) The antioxidant capacity and MDA levels of the ovary. Abbreviations: ROS, reactive oxygen species; GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; MDA, malondialdehyde. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). The oxidative stress marker ROS was significantly downregulated in the ovaries of aged hens supplemented with KAE, particularly in that of KAE2 group. This reduction was accompanied by significantly higher (p < 0.05) activities of GSH-Px, T-SOD, and CAT, while MDA content was reduced to a significant level (Fig. 5B-F).No significant differences were observed between KAE1 and KAE3 (p > 0.05). However, both groups showed lower ROS and higher antioxidant enzyme activities than the CON group (p < 0.05), which is consistent with the dose-response pattern observed in other parameters.MDA content in the KAE3 group was significantly lower than in the CON and KAE1 groups but did not differ significantly from KAE2 (p > 0.05). KAE inhibits prehierarchical follicles apoptosis The mRNA expression levels of mitochondrial copy number-related genes ATP6 and ND1 were significantly higher only in the KAE-fed groups (p < 0.05) and the highest in the KAE2 group. Although COX1 expression showed an increased trend but was not significant (p > 0.05) with other groups (Fig. 6A–C).Fig. 6Effects of dietary KAE supplementation on mitochondrial DNA copy number and the expression of apoptotic genes in prehierarchical follicles of aged laying hens. (A-F) The mRNA expression of ATP6, COX1, ND1, Bcl-2, Bax, Caspase9 in prehierarchical follicles of aged laying hens. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). Effects of dietary KAE supplementation on mitochondrial DNA copy number and the expression of apoptotic genes in prehierarchical follicles of aged laying hens. (A-F) The mRNA expression of ATP6, COX1, ND1, Bcl-2, Bax, Caspase9 in prehierarchical follicles of aged laying hens. Data are presented as the mean ± SE. Different letters mean significnat differences (p < 0.05). As shown in Fig. 6D-F, the anti-apoptotic gene Bcl-2 was significantly upregulated, whereas Bax and Caspase9 were downregulated (p < 0.05) in all KAE-fed groups, particularly in KAE2 group. The expression of Bax in KAE3 was significantly lower than that in CON group (p < 0.05), but not different from that in KAE1 (p > 0.05). Similarly, Caspase9 expression was significantly lower in KAE3 than in KAE1 and CON groups but not different from KAE2 (p > 0.05). Discussion In this study, we observed that dietary KAE supplementation alleviated the decline in egg production performance in aged laying hens, which was associated with improved intestinal integrity, enhanced hepatic lipid metabolism and yolk precursor synthesis, and reduced ovarian oxidative stress. These findings are consistent with previous studies in mammalian models demonstrating that KAE can improve intestinal barrier integrity, reduce liver lipid accumulation, and delay ovarian decline (Chen et al., 2023; Li et al., 2023; Santos et al., 2019). However, the relevance of these mammalian findings to poultry remains unclear, as species-specific differences in physiology, metabolism, and reproductive biology may influence the efficacy of KAE. Therefore, research on the regulatory effects of KAE in poultry, particularly in aged laying hens, is warranted, and our study provides novel evidence for its integrative effects on the gut-liver-ovary axis. This study found that dietary supplementation with different doses of KAE significantly affected the synthesis of yolk precursor substances, ovarian oxidative stress, apoptosis of pre-segmentation follicles, and hormone secretion in aged laying hens. These findings were supported by other studies on flavonoids (such as quercetin, rutin, and soy glycosides), which also indicated that they could improve the decline in reproductive performance of aged laying hens (Amevor et al., 2021; Wu et al., 2024; Xiao et al., 2019). The consistency among different flavonoid compounds suggests the possibility of a group effect, and this study provides the first clear evidence for KAE in this context. Our results showed that dietary supplementation with 150 mg/kg KAE significantly increased laying rate, feed conversion rate (FCR), and average egg weight, while significantly decreasing the feed-to-egg ratio (p < 0.05), with no significant effect on average daily feed intake (p > 0.05). These improvements in production performance can be attributed to the enhanced intestinal integrity, which increases nutrient absorption efficiency, as reflected by the improved villus height and V/C ratio in KAE supplemented hens. Simultaneously, KAE promoted hepatic yolk precursor synthesis (upregulation of VTG-II and ApoVLDL-II) and ovarian steroidogenesis (increased E2, FSH, LH, and P4 levels), collectively supporting follicular development and egg formation. The improved feed conversion efficiency without changes in feed intake further suggests that KAE enhances nutrient utilization rather than simply stimulating appetite. Consistent with our findings, a previous study reported that dietary supplementation with KAE and vitamin E significantly improved laying rate and average daily egg mass and reduced the feed-to-egg ratio in 49-week-old Jinghong No. 1 laying hens (Zhang et al., 2025). However, it should be noted that the study by (Zhang et al.2025) used KAE in combination with vitamin E, whereas our study evaluated KAE alone, which may influence the magnitude of the observed effects. In conclusion, dietary KAE supplementation at 150 mg/kg significantly increased laying rate, improved feed conversion rate, and reduced the feed-to-egg ratio (p < 0.05), demonstrating that KAE effectively alleviates the decline in production performance in aged laying hens. The intestine, liver, and ovary are closely interconnected through the "gut-liver-ovary axis," which plays a critical role in maintaining reproductive health and laying performance in poultry (Beldowska et al., 2023; Brégeon et al., 2022;Cui et al., 2020). In this study, dietary KAE supplementation significantly improved intestinal morphology, as evidenced by increased villus height (VH) and villus height-to-crypt depth (V/C) ratio, and decreased crypt depth (CD) in the duodenum, jejunum, and ileum, with the most pronounced effects observed at 150 mg/kg. While it is well-established that increased VH enhances nutrient absorption and decreased CD reflects healthy mucosal renewal (Gu et al., 2022), our findings provide novel evidence that KAE exerts dose-dependent effects on intestinal morphology in aged laying hens, with 150 mg/kg being the optimal dose. Furthermore, we observed differential regulation of tight junction genes: KAE significantly upregulated ZO-1 and claudin-1, but not Mucin-2 or Occludin, suggesting that KAE's barrier-protective effect is gene-specific. This partial effect distinguishes KAE from other flavonoids and highlights the need for further investigation into the selective regulation of intestinal barrier components. Importantly, these intestinal improvements were associated with subsequent enhancements in hepatic lipid metabolism and ovarian function, supporting the integrative role of the gut-liver-ovary axis in mediating KAE's effects. Nevertheless, the lack of response in Mucin-2 and Occludin suggests that the barrier-protective effect of KAE is partial and may be gene-specific. Previous studies have suggested that KAE possesses significant antioxidant and anti-inflammatory effects, and may reduce inflammatory damage to epithelial cells by inhibiting signaling pathways such as NF-κB and P38-MAPK (Qu et al., 2021; Yu et al., 2022; Xu et al., 2025). While our findings on improved intestinal morphology and barrier function are consistent with these reports, we acknowledge that the underlying signaling pathways were not directly examined in the present study. Therefore, the involvement of NF-κB and P38-MAPK in mediating KAE's effects on intestinal barrier function in aged laying hens remains speculative and warrants further investigation. Another study demonstrated that dietary supplementation with KAE and vitamin E could optimize gut microbiota composition in aged laying hens, creating a more balanced microecosystem and promoting the fermentation of indigestible carbohydrates into short-chain fatty acids (SCFAs) (Zhang et al., 2025). However, it should be noted that this study used KAE in combination with vitamin E, whereas our study evaluated KAE alone. Furthermore, gut microbiota was not examined in the present study, so the potential involvement of this mechanism remains speculative. Nevertheless, given the recognized role of SCFAs in nutrient absorption, this represents a plausible pathway through which KAE might exert its effects, warranting further investigation. Therefore, KAE enhances intestinal barrier function through improvements in intestinal villus morphology, epithelial cell renewal, and tight junction protein expression. Due to the close metabolic connection between the intestine and the liver, histological observations (Fig. 2A) and Oil Red O staining quantification (Fig. 2B) revealed that KAE supplementation significantly reduced hepatic lipid droplet density compared with the control group, indicating that KAE alleviates age-related hepatic lipid accumulation in aged hens. The observed reductions in intrahepatic triglyceride (TG) and total cholesterol (TC) levels in KAE groups suggest that KAE supplementation acts to improve lipid metabolism in aged hens. This is consistent with the modulation of the key factor MTTP, which is involved in the assembly and secretion of very-low-density lipoproteins (VLDL), facilitating lipid export and alleviating hepatic fat accumulation (Anastasia et al., 2021; Chen et al., 2025). Furthermore, the upregulation of PPAR-α indicates that KAE promotes lipid oxidative metabolism and energy expenditure, thereby further alleviating hepatic fat deposition (Bougarne et al., 2018). However, it is worth noting that the expression level of FAS was significantly higher in the KAE groups than in the control group (p < 0.05), with the highest expression observed in the KAE2 group. FAS is the rate limiting enzyme for long chain fatty acid synthesis, and its high expression is typically associated with excessive fat deposition (Wang et al., 2024). However, in the context of laying hens, hepatic FAS expression is closely linked to yolk precursor (VLDLy) synthesis, providing fatty acids for yolk assembly rather than pathological fat deposition (Richards et al., 2003). This interpretation is supported by our observation that KAE supplementation simultaneously reduced hepatic lipid accumulation (Fig. 2) while upregulating FAS expression. This apparent paradox may be explained by enhanced flux through lipogenic pathways: the fatty acids synthesized via FAS are preferentially channeled into VLDLy assembly and secreted into the bloodstream for ovarian uptake, rather than being stored as hepatic triglycerides. Additionally, the upregulation of FAS may represent a compensatory response to meet the increased metabolic demands of yolk precursor production in KAE supplemented hens. This is further supported by the concurrent upregulation of yolk precursor genes (VTG-II and ApoVLDL-II) and the enhanced expression of MTTP, which facilitates VLDL assembly and secretion. Thus, increased FAS expression in KAE supplemented hens reflects enhanced yolk synthesis capacity rather than pathological hepatic lipid accumulation. KAE significantly modulated the estrogen receptor signaling pathway, a key regulator of yolk precursor synthesis in laying hens. Specifically, KAE upregulated hepatic ER-α, and ER-β expression, which in turn promoted the transcription of downstream yolk precursor genes VTG-II and ApoVLDL-II (Cui et al., 2020; Li et al., 2014). VTG-II serves as the main yolk protein precursor, while ApoVLDL-II is the major polypeptide component of avian VLDL, facilitating lipid transport to the ovary (Li et al., 2014; Chen et al., 2025). In aged hens, serum estradiol (E2) levels and hepatic ER expression decline, leading to reduced yolk precursor synthesis capacity (Liu et al., 2018). However, KAE supplementation reversed this age related decline by enhancing ER mediated transcriptional activation of VTG-II and ApoVLDL-II. This was accompanied by the upregulation of PPAR-α, FAS, and MTTP, which support lipid metabolism and VLDL assembly and secretion (Bougarne et al., 2018;Wang et al., 2025;Chen et al., 2025). These results suggest that dietary supplementation with KAE supports the coordination of hepatic and ovarian functions in aged laying hens, as evidenced by improved hepatic morphology, enhanced lipid metabolism, and upregulation of yolk precursor synthesis related genes. The present findings on KAE-mediated upregulation of hepatic ER-α and ER-β are particularly relevant in the context of the dynamic regulation of estrogen receptor signaling during the laying cycle. During active laying, circulating estradiol (E2) binds to hepatic ER-α, the predominant ER subtype in the avian liver, triggering the transcriptional activation of yolk precursor genes including VTG-II and ApoVLDL-II, as well as genes involved in fatty acid metabolism and lipid transport (Li et al., 2014; Cui et al., 2020). This estrogen-ER-α axis is essential for the massive hepatic mobilization of fatty acids required for yolk deposition (Yao et al., 2021). During a pause in laying induced by natural factors such as fasting, however, plasma estradiol concentrations decrease significantly, accompanied by reduced hepatic lipid synthesis. Interestingly, fasting has been shown to upregulate hepatic ER-α and ER-β mRNA expression during oviduct regression, suggesting a dynamic regulatory response of ER signaling to nutritional status (Socha et al., 2017). These observations highlight the central role of the estrogen-ER axis in linking nutritional status, hepatic metabolism, and reproductive function in hens. In the context of our study, KAE supplementation enhanced hepatic ER expression and yolk precursor gene transcription, suggesting that KAE may help maintain hepatic responsiveness to estrogen signaling even in aged hens, thereby supporting continued yolk synthesis and reproductive performance. In this study, serum E2, FSH, LH, and P4 concentrations were significantly higher in the KAE2 group (150 mg/kg) compared with the control and other treatment groups, indicating that KAE supplementation enhances reproductive hormone secretion in aged laying hens. These elevated hormone levels, together with the upregulated expression of their corresponding receptors (ER-α, ER-β, FSHR, and LHR) in ovarian follicles, suggest that KAE promotes follicular development and steroidogenesis by enhancing both hormone production and receptor responsiveness. The results of this study showed that serum E2, FSH, LH, and P4 concentrations were significantly higher in the KAE2 group (150 mg/kg) than in the other groups (p < 0.05). This enhancement of endocrine function may be attributed to KAE's upregulation of hormone receptors (ER-α, ER-β, FSHR, and LHR) in ovarian follicles, thereby amplifying target tissue responsiveness to gonadotropic signals. Furthermore, the observed increase in serum FSH and LH levels suggests potential modulation of the hypothalamic-pituitary-gonadal (HPG) axis. Notably, the dose-response relationship was non-linear: while KAE2 (150 mg/kg) consistently showed the most pronounced effects, KAE3 (300 mg/kg) exhibited diminished responses. This biphasic pattern may reflect receptor saturation or desensitization at higher concentrations, a phenomenon commonly observed for flavonoids and other phytochemicals (Calabrese et al., 2025). We further examined the expression of ER-α, ER-β, FSHR, and LHR in ovarian prehierarchical follicles (1-8 mm). The mRNA expression of these receptors was significantly upregulated in the KAE2 group (p < 0.05) (Fig. 4E-H). To clarify the mechanism, it is important to distinguish between systemic and local effects. Systemically, KAE elevated circulating FSH and LH levels (Fig. 4A-D). Locally, KAE upregulated FSHR and LHR expression in ovarian follicles (Fig. 4E-H). The coordinated upregulation of both systemic gonadotropins and local receptor expression synergistically enhances follicular development: FSH binds to upregulated FSHR on granulosa cells, promoting granulosa cell proliferation and stimulating the synthesis of progesterone and estrogens (Johnson et al., 2001; Al-Musawi et al., 2007). LH acts on theca cells via upregulated LHR to promote the synthesis of androgens, which are then directly converted to estrogens by theca cells, supporting follicular growth and maturation (Johnson et al., 2001; Al-Musawi et al., 2007; Porter et al., 1989). It is important to note, however, that the steroidogenic capacity of ovarian follicles is highly dependent on their stage of maturation. For instance, granulosa cells from small yellow follicles (6-8 mm) are virtually steroidogenically incompetent, with low basal progesterone production, whereas those from 9 to 12 mm follicles acquire robust steroidogenic capacity and responsiveness to FSH stimulation (Tilly et al., 1991). The present study focused on prehierarchical follicles (1-8 mm), which represent an early stage of follicle development. Thus, the observed upregulation of hormone receptors in these follicles reflects KAE's effects at this specific developmental stage, and further studies are needed to determine whether similar effects occur in more mature, hierarchical follicles. Thus, KAE promotes ovarian steroidogenesis and follicular maturation by simultaneously enhancing systemic gonadotropin secretion and local receptor responsiveness. The findings of this study are consistent with and extend those of Amevor et al. (2021), who reported that quercetin (400 mg/kg) combined with vitamin E increased serum E2, FSH, and LH levels, and upregulated ovarian FSHR and LHR expression in aged breeder hens. Our study extends these findings by demonstrating that KAE alone, at a lower dose (150 mg/kg), produces comparable effects on these reproductive hormones and their receptors. Notably, while Amevor et al. focused on the liver-blood-ovary axis, our study provides novel evidence that KAE acts through the integrative gut-liver-ovary axis, a pathway not previously examined for KAE in poultry. This comparison highlights both the consistency of flavonoid effects and the novelty of our KAE specific findings. Our results demonstrated that KAE supplementation, particularly at 150 mg/kg, significantly reduced ROS accumulation, increased GSH-Px, T-SOD, and CAT activities, and decreased MDA levels in aged hen ovaries. These antioxidant enzymes play a defensive role against oxidative stress, while MDA reflects lipid peroxidation damage to cell membranes (Shi et al., 2021). KAE also upregulated ovarian ATP6, COX1, ND1, and Bcl-2 expression while downregulating Bax and Caspase9 (p < 0.05). Although these genes are involved in mitochondrial function and apoptosis regulation, we acknowledge that mitochondrial function was not directly measured in this study. Nevertheless, the observed changes are consistent with the established roles of these genes: ATP6, COX1, and ND1 are essential for mitochondrial respiratory chain function, and their downregulation under oxidative stress impairs ATP synthesis and triggers cytochrome c release and caspase-dependent apoptosis (Yan et al., 2021; Costantini et al., 2002). Moreover, ROS activates the MAPK/JNK/p38 pathway, upregulating pro-apoptotic Bax and downregulating anti-apoptotic Bcl-2, thereby promoting follicular cell death (Lee C et al., 2023). These findings are consistent with previous in vitro studies showing that KAE alleviates oocyte aging and promotes embryonic development by reducing oxidative stress and improving mitochondrial function (Zeng et al., 2022; Yao et al., 2019; Zhao et al., 2020). However, the present study was conducted in vivo using whole prehierarchical follicles, and the molecular mechanisms underlying the protective effects of KAE at the cellular level were not directly examined. Therefore, further in vitro studies using chicken granulosa cells are warranted to directly validate the mechanisms by which KAE improves cell growth and prevents oxidative stress in hens. Conclusion In summary, this study demonstrated that KAE, particularly at 150 mg/kg, maintains the functional balance of the gut-liver-ovary axis by enhancing intestinal barrier integrity, improving hepatic lipid metabolism and yolk precursor synthesis, and strengthening ovarian antioxidant defense and hormonal regulation (Fig. 7). These findings suggest that dietary KAE supplementation at 150 mg/kg could serve as an effective nutritional strategy for delaying reproductive decline and improving egg production in aged laying hens, offering a practical approach to extending the productive lifespan of commercial layer flocks.Fig. 7Schematic diagram of kaempferol improving laying performance of aged laying hens through the gut-liver-ovary axis. Schematic diagram of kaempferol improving laying performance of aged laying hens through the gut-liver-ovary axis. Author contributions Zhichao Xu, Yuanyuan Zhou, Shiyu Zheng, Yan Ren, Wenhai Qian, Sadequllah Ahmadi, Dikai Zhang, and Rifu Xu contributed to the acquisition, analysis, and interpretation of data, including experiments, animal trials, sample collection/processing, bioinformatics analysis, and statistical analysis. Ning Qin and Xue Sun conceived and designed the research, supervised the overall project, and provided resources and funding. Zhichao Xu drafted the initial manuscript, and all authors critically reviewed and revised it for important intellectual content. All authors have reviewed and approved the final version of the manuscript and agree to be personally and publicly accountable for all aspects of this work, ensuring that any questions regarding the accuracy or integrity of the research are thoroughly investigated and resolved. Funding This study was supported by the 10.13039/100007847Jilin Province Science and Technology Development Plan Project (No.20260102156JC); the 10.13039/501100004543China CSC scholarship (No.202308220135). Ethics approval and consent to participate All procedures were carried out according to the Institutional Animal Care and Use Committee (IACUC) of Jilin Agricultural University (Changchun, China; Permission No. GR (J) 240520006). Consent for publication Not applicable. Disclosures The authors declare no conflict of interest.